AAAAAA

   
Results: 1-25 | 26-29 |
Results: 26-29/29
MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIAS (AML) WITH 17P DELETION, SPECIFIC DYSGRANULOPOIESIS AND A HIGH-INCIDENCE OF P53MUTATIONS - A NEW MORPHOLOGICAL-CYTOGENETIC-MOLECULAR ENTITY
Authors: PREUDHOMME C LAI JL ZANDECKI M VANRUMBEKE M FLACTIF M LEPELLEY P WATTEL E FENAUX P
Citation: C. Preudhomme et al., MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIAS (AML) WITH 17P DELETION, SPECIFIC DYSGRANULOPOIESIS AND A HIGH-INCIDENCE OF P53MUTATIONS - A NEW MORPHOLOGICAL-CYTOGENETIC-MOLECULAR ENTITY, Blood, 84(10), 1994, pp. 10000313-10000313
P53 MUTATIONS, RESPONSE TO CHEMOTHERAPY AND SURVIVAL IN HEMATOLOGICALMALIGNANCIES
Authors: WATTEL E PREUDHOMME C DERVITE I VANRUMBEKE M FLACTIF M LAI JL BAUTERS F FENAUX P
Citation: E. Wattel et al., P53 MUTATIONS, RESPONSE TO CHEMOTHERAPY AND SURVIVAL IN HEMATOLOGICALMALIGNANCIES, Blood, 84(10), 1994, pp. 10000615-10000615
ABSENCE OF REARRANGEMENTS OF THE NF1 GENE IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
Authors: PREUDHOMME C QUESNEL B VANRUMBEKE M VACHEE A LAI JL FENAUX P
Citation: C. Preudhomme et al., ABSENCE OF REARRANGEMENTS OF THE NF1 GENE IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML), Blood, 82(10), 1993, pp. 10000531-10000531
DETECTION OF P53 GENE-MUTATIONS IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML) COMBINING SSCP, IMMUNOCYTOCHEMISTRY ANDANTIBODY DETECTION
Authors: PREUDHOMME C LUBIN R LEPELLEY P LEGROS Y VANRUMBEKE M QUESNEL B VACHEE A LAI JL SOUSSI T FENAUX P
Citation: C. Preudhomme et al., DETECTION OF P53 GENE-MUTATIONS IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML) COMBINING SSCP, IMMUNOCYTOCHEMISTRY ANDANTIBODY DETECTION, Blood, 82(10), 1993, pp. 10000531-10000531
Risultati: 1-25 | 26-29 |